These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 9271492)
1. A cysteine-3 to serine mutation of the G-protein Gi1 alpha abrogates functional activation by the alpha 2A-adrenoceptor but not interactions with the beta gamma complex. Wise A; Grassie MA; Parenti M; Lee M; Rees S; Milligan G Biochemistry; 1997 Sep; 36(35):10620-9. PubMed ID: 9271492 [TBL] [Abstract][Full Text] [Related]
2. Hydrophobicity of residue351 of the G protein Gi1 alpha determines the extent of activation by the alpha 2A-adrenoceptor. Bahia DS; Wise A; Fanelli F; Lee M; Rees S; Milligan G Biochemistry; 1998 Aug; 37(33):11555-62. PubMed ID: 9708991 [TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the efficacy of A1 adenosine receptor activation of Gi/o alpha G proteins following coexpression of receptor and G protein and expression of A1 adenosine receptor-Gi/o alpha fusion proteins. Wise A; Sheehan M; Rees S; Lee M; Milligan G Biochemistry; 1999 Feb; 38(8):2272-8. PubMed ID: 10029519 [TBL] [Abstract][Full Text] [Related]
4. Interactions of the alpha2A-adrenoceptor with multiple Gi-family G-proteins: studies with pertussis toxin-resistant G-protein mutants. Wise A; Watson-Koken MA; Rees S; Lee M; Milligan G Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):721-8. PubMed ID: 9032459 [TBL] [Abstract][Full Text] [Related]
6. Rescue of functional interactions between the alpha2A-adrenoreceptor and acylation-resistant forms of Gi1alpha by expressing the proteins from chimeric open reading frames. Wise A; Milligan G J Biol Chem; 1997 Sep; 272(39):24673-8. PubMed ID: 9305937 [TBL] [Abstract][Full Text] [Related]
7. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits. Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820 [TBL] [Abstract][Full Text] [Related]
8. Mutation of cysteine 214 in Gi1 alpha subunit abolishes its endogenous GTPase activity. Wang Y; Tawa G; Smith D; Krishnamurthy G; Young KH Biochem J; 2004 May; 379(Pt 3):673-9. PubMed ID: 14725508 [TBL] [Abstract][Full Text] [Related]
9. Molecular interaction of the human alpha 2-C10-adrenergic receptor, when expressed in Rat-1 fibroblasts, with multiple pertussis toxin-sensitive guanine nucleotide-binding proteins: studies with site-directed antisera. McClue SJ; Milligan G Mol Pharmacol; 1991 Nov; 40(5):627-32. PubMed ID: 1658601 [TBL] [Abstract][Full Text] [Related]
10. Alterations in guanine nucleotide regulatory protein expression and activity in human hepatocellular carcinoma. Schmidt CM; McKillop IH; Cahill PA; Sitzmann JV Hepatology; 1997 Nov; 26(5):1189-94. PubMed ID: 9362361 [TBL] [Abstract][Full Text] [Related]
11. Partial rescue of functional interactions of a nonpalmitoylated mutant of the G-protein G alpha s by fusion to the beta-adrenergic receptor. Ugur O; Onaran HO; Jones TL Biochemistry; 2003 Mar; 42(9):2607-15. PubMed ID: 12614155 [TBL] [Abstract][Full Text] [Related]
12. Reciprocal modulation of alpha(2A)-adrenoceptor and G(alpha o) protein states as determined by carboxy-terminal mutagenesis of a G(alpha o) protein. Wurch T; Okuda J; Pauwels PJ Mol Pharmacol; 2001 Oct; 60(4):666-73. PubMed ID: 11562427 [TBL] [Abstract][Full Text] [Related]
13. Targeting of a G alpha subunit (Gi1 alpha) and c-Src tyrosine kinase to caveolae membranes: clarifying the role of N-myristoylation. Song KS; Sargiacomo M; Galbiati F; Parenti M; Lisanti MP Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):293-303. PubMed ID: 9193783 [TBL] [Abstract][Full Text] [Related]
14. Loss of activation of Gs but not Gi following expression of an alpha2A-adrenoceptor-Gi1alpha fusion protein. Sautel M; Milligan G FEBS Lett; 1998 Sep; 436(1):46-50. PubMed ID: 9771891 [TBL] [Abstract][Full Text] [Related]
15. The role of Gi proteins in reduced vasorelaxation response to beta-adrenoceptor agonists in rat aorta during maturation. Baloğlu E; Kiziltepe O; Gürdal H Eur J Pharmacol; 2007 Jun; 564(1-3):167-73. PubMed ID: 17395174 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of type II adenylyl cyclase by chemoattractant formyl peptide and C5a receptors. Tsu RC; Allen RA; Wong YH Mol Pharmacol; 1995 Apr; 47(4):835-41. PubMed ID: 7723745 [TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of adenylyl cyclase by octopamine via a human cloned alpha 2A-adrenoceptor. Airriess CN; Rudling JE; Midgley JM; Evans PD Br J Pharmacol; 1997 Sep; 122(2):191-8. PubMed ID: 9313925 [TBL] [Abstract][Full Text] [Related]
18. The effect of site-directed mutagenesis of two transmembrane serine residues on agonist-specific coupling of a cloned human alpha2A-adrenoceptor to adenylyl cyclase. Rudling JE; Kennedy K; Evans PD Br J Pharmacol; 1999 Jun; 127(4):877-86. PubMed ID: 10433494 [TBL] [Abstract][Full Text] [Related]
19. Enhanced Gi-protein-mediated mitogenesis following chronic ethanol exposure in a rat model of experimental hepatocellular carcinoma. McKillop IH; Vyas N; Schmidt CM; Cahill PA; Sitzmann JV Hepatology; 1999 Feb; 29(2):412-20. PubMed ID: 9918917 [TBL] [Abstract][Full Text] [Related]
20. Structural requirements for G(o) activation by receptor-derived peptides: activation and modulation domains of the alpha 2-adrenergic receptor i3c region. Wade SM; Scribner MK; Dalman HM; Taylor JM; Neubig RR Mol Pharmacol; 1996 Aug; 50(2):351-8. PubMed ID: 8700143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]